Health

Why Pfizer ended testing on once-daily weight-loss pill treatment

Pfizer announced it is ending its development of a once-daily weight-loss pill treatment for obesity. It comes after a participant in one of the trials experienced a possible drug-induced liver injury and recovered after the medication was stopped.

Apr 15, 2025 - 19:00
Why Pfizer ended testing on once-daily weight-loss pill treatment
Pfizer announced it is ending its development of a once-daily weight-loss pill treatment for obesity. It comes after a participant in one of the trials experienced a possible drug-induced liver injury and recovered after the medication was stopped.
Read More

Tags:

Previous Article

Autism rates have risen to 1 in 31 school-age children, CDC reports

Next Article

Inside an anti-vaccine autism summit in the age of RFK Jr.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Boar’s Head Plants Struggled with Insects and Slime, Records Show

Boar’s Head Plants Struggled with Insects and Slime, Re...

Jan 14, 2025

Congo reports more than 1,000 new mpox cases in a week. African authorities ask for vaccines

Congo reports more than 1,000 new mpox cases in a week....

Aug 21, 2024

What Is Spondylolisthesis, the Spine Condition Reported to Plague Luigi Mangione?

What Is Spondylolisthesis, the Spine Condition Reported...

Feb 4, 2025